[go: up one dir, main page]

AU2342299A - Compositions and methods for detecting and treating breast cancer - Google Patents

Compositions and methods for detecting and treating breast cancer

Info

Publication number
AU2342299A
AU2342299A AU23422/99A AU2342299A AU2342299A AU 2342299 A AU2342299 A AU 2342299A AU 23422/99 A AU23422/99 A AU 23422/99A AU 2342299 A AU2342299 A AU 2342299A AU 2342299 A AU2342299 A AU 2342299A
Authority
AU
Australia
Prior art keywords
compositions
detecting
methods
breast cancer
treating breast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23422/99A
Inventor
Jennifer R. Adelman
Paul B. Fisher
Neil I. Goldstein
Fei Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GENQUEST Inc
Original Assignee
GENQUEST Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GENQUEST Inc filed Critical GENQUEST Inc
Publication of AU2342299A publication Critical patent/AU2342299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU23422/99A 1998-01-26 1999-01-25 Compositions and methods for detecting and treating breast cancer Abandoned AU2342299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7252698P 1998-01-26 1998-01-26
US60072526 1998-01-26
PCT/US1999/001556 WO1999037775A2 (en) 1998-01-26 1999-01-25 Compositions and methods for detecting and treating breast cancer

Publications (1)

Publication Number Publication Date
AU2342299A true AU2342299A (en) 1999-08-09

Family

ID=22108171

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23422/99A Abandoned AU2342299A (en) 1998-01-26 1999-01-25 Compositions and methods for detecting and treating breast cancer

Country Status (2)

Country Link
AU (1) AU2342299A (en)
WO (1) WO1999037775A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489101B1 (en) 1999-11-30 2002-12-03 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
CA2392510A1 (en) 1999-11-30 2001-06-07 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
AU2006202984B2 (en) * 2000-04-04 2009-12-03 University Of Rochester A gene differentially expressed in breast and bladder cancer and encoded polypeptides
EP1788085A1 (en) * 2000-04-04 2007-05-23 University Of Rochester A gene differentially expressed in breast and bladder cancer and encoded polypeptides
WO2001074859A2 (en) 2000-04-04 2001-10-11 University Of Rochester A gene differentially expressed in breast and bladder cancer and encoded polypeptides
US20030049651A1 (en) * 2001-03-05 2003-03-13 Mount Sinai Hospital Tumor associated proteins
CN100418981C (en) 2002-06-10 2008-09-17 瓦西尼斯公司 Genes differentially expressed in breast and bladder cancer and encoded polypeptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786158A (en) * 1992-04-30 1998-07-28 Yale University Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
AU5168393A (en) * 1992-09-30 1994-04-26 Yale University Therapeutic and diagnostic methods and compositions based on transducin-like enhancer of split proteins and nucleic acids
US6037134A (en) * 1994-03-07 2000-03-14 New York University Medical Center Methods that detect compounds that disrupt receptor tyrosine kinase/GRB-7 complexes
US5668267A (en) * 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
US5914238A (en) * 1996-06-05 1999-06-22 Matritech, Inc. Materials and methods for detection of breast cancer

Also Published As

Publication number Publication date
WO1999037775A3 (en) 1999-11-04
WO1999037775A2 (en) 1999-07-29

Similar Documents

Publication Publication Date Title
HUP0201436A3 (en) Methods and compositions for treating solid tumors
AU3105700A (en) Methods for detection of antiestrogen-resistant breast cancer
AU2212299A (en) Compositions and methods for the treatment of tumor
EP1176964B8 (en) Uses of et743 for treating cancer
HUP0104857A3 (en) New cancer treatments
AU3391200A (en) Compositions and methods for breast cancer therapy and diagnosis
GB2318734B (en) Methods of preventing breast cancer
AU8259798A (en) Method for detection of breast cancer
IL124650A0 (en) Methods and therapeutic compositions for treating cancer
GB9805877D0 (en) Cancer
AU8068198A (en) Methods for treating human cancers
AU2342299A (en) Compositions and methods for detecting and treating breast cancer
AU5369498A (en) Compounds and methods for treating cancer
AU5097099A (en) Methods and compositions for cancer treatment
AU3429300A (en) Means for diagnosing and treating carcinoma
GB9819999D0 (en) Treatment of cancer
GB9804361D0 (en) Cancer treatment
AU2292801A (en) Compositions and methods for treatment of breast cancer
AU2474699A (en) Compositions and methods for detecting and treating prostate cancer
GB9903035D0 (en) Treating cancer
GB9827102D0 (en) New cancer treatments
AU1471300A (en) Compositions and methods for treatment of cancer
GB2334579B (en) Treating cancer
AU4598100A (en) Treating cancer
HK1033173A (en) Treating cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase